| pubmed-article:7989946 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:7989946 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:7989946 | lifeskim:mentions | umls-concept:C0024419 | lld:lifeskim |
| pubmed-article:7989946 | lifeskim:mentions | umls-concept:C0092801 | lld:lifeskim |
| pubmed-article:7989946 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:7989946 | pubmed:issue | 12 | lld:pubmed |
| pubmed-article:7989946 | pubmed:dateCreated | 1995-1-12 | lld:pubmed |
| pubmed-article:7989946 | pubmed:abstractText | To assess the activity of 2-chlorodeoxyadenosine (2CdA) as primary therapy for patients with Waldenström's macroglobulinemia. | lld:pubmed |
| pubmed-article:7989946 | pubmed:language | eng | lld:pubmed |
| pubmed-article:7989946 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7989946 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:7989946 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:7989946 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:7989946 | pubmed:month | Dec | lld:pubmed |
| pubmed-article:7989946 | pubmed:issn | 0732-183X | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:RossWW | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:WeberDD | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:EsteyEE | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:CabanillasFF | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:KeatingMM | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:O'BrienSS | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:AlexanianRR | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:DimopoulosM... | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:KantarjianHH | lld:pubmed |
| pubmed-article:7989946 | pubmed:author | pubmed-author:DelasalleKK | lld:pubmed |
| pubmed-article:7989946 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:7989946 | pubmed:volume | 12 | lld:pubmed |
| pubmed-article:7989946 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:7989946 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:7989946 | pubmed:pagination | 2694-8 | lld:pubmed |
| pubmed-article:7989946 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:meshHeading | pubmed-meshheading:7989946-... | lld:pubmed |
| pubmed-article:7989946 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:7989946 | pubmed:articleTitle | Primary therapy of Waldenström's macroglobulinemia with 2-chlorodeoxyadenosine. | lld:pubmed |
| pubmed-article:7989946 | pubmed:affiliation | Department of Hematology, University of Texas M.D. Anderson Cancer Center, Houston. | lld:pubmed |
| pubmed-article:7989946 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:7989946 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:7989946 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:7989946 | lld:pubmed |
